phrykt

Pfizer Inc (PFE): who owns it and who trades it

As of Nov 16, 2026, PFE insiders reported 2 open-market sales worth $135K and 3 purchases worth $3M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jennifer B. Damico (Vice president), with $135K. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Pfizer

From the latest filings

Overall: about as much buying as selling. Congress mostly sold. Insiders and famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PFE

2,814 funds and institutions reported PFE shares worth $101B at the end of Q2 2026, about 71% of the company. The largest holder is BlackRock, Inc. with 9.3%.

Funds and institutions (13F) 71%Everyone else 29%

10 largest owners, by share of the company

BlackRock, Inc.9.3%
Vanguard Capital Management LLC6.5%
State Street Corp5.4%
California State Teachers Retirement System3.8%
Geode Capital Management, LLC2.4%
Vanguard Portfolio Management LLC2.1%
Fisher Asset Management, LLC1.9%
Morgan Stanley1.7%
Norges Bank1.1%
Northern Trust Corp1.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.529.67M9.29%$12.8B+6%
Vanguard Capital Management LLC372.15M6.53%$9B+1%
State Street Corp307.09M5.39%$7.4B+2%
California State Teachers Retirement System217.98M3.82%$9.1B+2321%
Geode Capital Management, LLC135.28M2.37%$3.2B+1%
Vanguard Portfolio Management LLC119.24M2.09%$2.9B+2%
Fisher Asset Management, LLC109.07M1.91%$2.6B+4%
Morgan Stanley96.35M1.69%$2.3B+4%
Norges Bank61.51M1.08%$1.5B–
Northern Trust Corp59.08M1.04%$1.4B-5%
Bank of New York Mellon Corp57.88M1.02%$1.4B+7%
Massachusetts Financial Services Co56.55M0.99%$1.4B-1%
State Farm Mutual Automobile Insurance Co54.51M0.96%$1.3BNo change
Goldman Sachs Group Inc52.99M0.93%$1.3B+12%
Charles Schwab Investment Management Inc52.55M0.92%$1.3B+1%
Bank of America Corp43.59M0.76%$1B-6%
Legal & General Group Plc43.23M0.76%$1B-1%
Dimensional Fund Advisors LP38.06M0.67%$917M+4%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC36.16M0.63%$871M+5%
Amundi33.53M0.59%$807M-18%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PFE insiders reported $3M of open-market purchases and $135K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$3M
3 trades, 3 people
Sales, 12 months
$135K
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 12, 2026
Filed Aug 12, 2026

Purchases and sales by month

$3M$3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 12, 2026Albert BourlaCEOPurchase38,000$26.34$1MForm 4
Aug 5, 2026Jennifer B. DamicoVice presidentSale3,278$25.40$83.3KForm 4
Aug 5, 2026Ronald E BlaylockDirectorPurchase39,231$25.46$999KForm 4
Aug 5, 2026Mortimer J BuckleyDirectorPurchase37,632$25.52$960KForm 4
Jun 9, 2026Jennifer B. DamicoVice presidentSale2,000$25.70$51.4KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Albert BourlaChairman & CEO, Director$1M–Aug 12, 2026
Ronald E BlaylockDirector$999K–Aug 5, 2026
Mortimer J BuckleyDirector$960K–Aug 5, 2026
Jennifer B. DamicoSVP & Controller–$135KAug 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PFE short interest

Low short interest. 2.4% of PFE shares are sold short: about 1 share in 42. Over the last 12 reports the number of shares short went down 15%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 134.42M PFE shares were sold short, 2.4% of the shares outstanding, down 2.5% from the report before. At the average daily volume of 29.32M shares, buying them all back would take about 4.6 trading days (days to cover).

Shares short, % of all shares

2.36%May 15Oct 302.95%

Days to cover

4.6May 15Oct 305.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026134.42M2.36%-2%29.32M4.6
Oct 15, 2026137.82M2.42%-8%30.83M4.5
Sep 30, 2026150.22M2.64%-3%34.03M4.4
Sep 15, 2026155.20M2.72%+2%31.66M4.9
Aug 31, 2026151.54M2.66%+2%35.02M4.3
Aug 14, 2026149.27M2.62%-8%42.26M3.5
Jul 31, 2026161.48M2.83%-1%38.59M4.2
Jul 15, 2026163.82M2.87%+0%42.81M3.8
Jun 30, 2026163.58M2.87%+1%60.91M2.7
Jun 15, 2026162.08M2.84%-0%35.20M4.6
May 29, 2026162.66M2.85%+3%32.81M5.0
May 15, 2026157.46M2.76%+12%38.20M4.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded PFE

Since Nov 17, 2024, 15 members of Congress reported 11 purchases and 20 sales of PFE. The latest was a sale by Tommy Tuberville on Jun 8, 2026, reported Jul 16, 2026.

Purchases 11Sales 20

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Jun 8, 2026Tommy Tuberville (R-AL)Sale$15K–$50KJointJul 16, 2026Report
Mar 24, 2026Alan Armstrong (R-OK)Sale$50K–$100KSelfJul 21, 2026Report
Mar 13, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfApr 7, 2026Report
Feb 10, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMar 9, 2026Report
Dec 31, 2025J. French Hill (R-AR)Sale$100K–$250KSelfJan 23, 2026Report
Dec 19, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJan 12, 2026Report
Nov 18, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfDec 15, 2025Report
Aug 5, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfSep 12, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseSep 12, 2025Report
Jul 16, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Julia Letlow (R-LA)Purchase$1K–$15KSelfJan 13, 2026Report
Jun 3, 2025Josh Gottheimer (D-NJ)Sale$1K–$15KJointJul 16, 2025Report
Jun 3, 2025Ron Wyden (D-OR)Sale$1K–$15KSpouseJul 2, 2025Report
May 30, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJun 6, 2025Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$15K–$50KSelfMay 31, 2025Report
Apr 29, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMay 6, 2025Report
Apr 21, 2025Bruce Westerman (R-AR)Sale$1K–$15KSelfMay 12, 2025Report
Apr 11, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfMay 8, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$15K–$50KSelfApr 28, 2025Report
Mar 31, 2025Gilbert Ray Cisneros, Jr. (D-CA)Sale$15K–$50KSelfApr 7, 2025Report
Mar 10, 2025Carol D. Miller (R-WV)Sale$15K–$50KSpouseAug 13, 2026Report
Mar 10, 2025Carol D. Miller (R-WV)Sale$1K–$15KSelfApr 11, 2025Report
Mar 3, 2025Bruce Westerman (R-AR)Purchase$1K–$15KSelfApr 16, 2025Report
Feb 26, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfMar 6, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$15K–$50KSelfMar 27, 2025Report
Feb 24, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfMar 9, 2025Report
Feb 13, 2025John Boozman (R-AR)Sale$1K–$15KJointMar 6, 2025Report
Feb 12, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMar 12, 2025Report
Jan 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfFeb 11, 2025Report
Jan 15, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointFeb 12, 2025Report
Nov 26, 2024Michael A. Rulli (R-OH)Sale$1K–$15KSelfAug 7, 2026Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Pfizer company events

Pfizer filed 10 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026LeadershipPfizer Inc. announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026. Filing
  2. Nov 3, 2026ResultsReleased financial results. Filing
  3. Aug 4, 2026ResultsReleased financial results. Filing
  4. Jun 18, 2026AnnouncementShared information with investors. Filing
  5. Jun 18, 2026LeadershipDeparture of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
  6. May 5, 2026ResultsReleased financial results. Filing
  7. Apr 27, 2026VoteReported shareholder vote results. Filing
  8. Feb 3, 2026ResultsReleased financial results. Filing
  9. Dec 16, 2025AnnouncementShared information with investors. Filing
  10. Nov 21, 2025AnnouncementPfizer Inc. completed a public offering of $500 million of Floating Rate Notes due 2027, $1 billion of 3.875% Notes due 2027, $1 billion of 4.200% Notes due 2030, $1.25 billion of 4.500% Notes due 2032, $1.25 billion of 4.875% Notes due 2035, $500 million of 5.600% Notes due 2055 and $500 million… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Pfizer makes money

United States brought in 59% of Pfizer's revenue ($37.1B of $62.6B) in 2025. International Developed Markets was next, at 26%.

By region, 2025

United States$37.1B · 59%
International Developed Markets$16.2B · 26%
International Emerging Markets$9.3B · 15%

From Pfizer's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 26, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Pfizer financials

Famous investors that hold PFE

10 of the 50 well-known investors we track reported holding PFE in their latest 13F filing. The largest position is Ken Fisher's, worth $3.2B.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 2026112.12M$3.2B0.9%+3%
Richard Pzena · Pzena Investment ManagementQ3 20266.05M$173M0.5%+2%
Ken Griffin · Citadel AdvisorsQ3 20264.74M$135M0.1%-23%
Jeremy Grantham · GMOQ3 20262.26M$64.6M0.1%+4%
Jim Simons · Renaissance TechnologiesQ3 20261.99M$56.7M0.1%New
Israel Englander · Millennium ManagementQ3 20261.74M$49.6M0.0%+213%
Prem Watsa · Fairfax Financial HoldingsQ3 20261.42M$40.4M1.5%+36%
Paul Tudor Jones · Tudor Investment CorpQ3 2026598,828$17.1M0.1%-14%
Ray Dalio · Bridgewater AssociatesQ3 2026477,929$13.6M0.1%+165%
Lee Ainslie · Maverick CapitalQ3 202696,528$2.8M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Pfizer Inc (PFE) stock

Who owns the most PFE stock?

The largest reported owner of Pfizer Inc (PFE) is BlackRock, Inc., with 9.3% of the company. In total, 2,814 funds and institutions reported holding PFE at the end of Q2 2026, together about 71% of the shares. See the largest owners.

Are PFE insiders buying or selling?

In the last 12 months, PFE insiders reported 3 open-market purchases worth $3M and 2 sales worth $135K. The latest trade was on Aug 12, 2026. See every trade.

What is the short interest in PFE?

As of Oct 30, 2026, 134.42M PFE shares were sold short, 2.4% of the shares outstanding, down 2.5% from the report before. At the average daily volume of 29.32M shares, buying them all back would take about 4.6 trading days (days to cover). See the history.

Have members of Congress traded PFE?

Yes. 15 members of Congress reported 11 purchases and 20 sales of PFE since Nov 17, 2024. The latest was reported on Aug 13, 2026. See the trades.

How does Pfizer make money?

United States brought in 59% of Pfizer's revenue ($37.1B of $62.6B) in 2025. International Developed Markets was next, at 26%. See the full split.

Which famous investors hold PFE?

10 of the 50 well-known investors we track reported PFE in their latest 13F filing, including Ken Fisher, Richard Pzena, Ken Griffin. The largest position is worth $3.2B. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.